EVH today
$4.75-$0.25 (-4.91%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourLeaning Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns up above $6.25
Key levels
Resistance$5.52
Resistance$4.95
Support$4.54
Support$4.08
Latest news & SEC filings
ProductHumana, Evolent Health roll out oncology care program
AnalystOppenheimer keeps Outperform rating on Evolent Health, lifts price target
AnalystOppenheimer keeps Outperform rating on Evolent Health, lifts target to $7
All EVH news →About Evolent
Evolent offers specialty care management to insurers and organizations that take on medical risk. It serves patients with cancer, heart conditions, and bone and muscle disorders through clinical guidelines, provider networks, and software. The company also supplies administrative support, such as plan administration and prescription drug management. Its operations are in the United States.
Based on the company's 10-K filed Feb 25, 2026.
NYSE · Industrials
Evolent Health, Inc. (EVH)
What Is the Price Target for EVH?
SEPT Low Target
$6.00
SEPT Mid Target
$6.00
SEPT High Target
$7.00
Analyst Consensus
$6.00
Is EVH a Buy or Sell Right Now?
Thesis
- •Revenue growing -26.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EVH.
Start Free Trial →Is EVH Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$6.12
13
Moat Score
NONE
4/9
Piotroski Score
-0.4
Altman Z-Score
What Is Smart Money Doing with EVH?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| McCarthy Daniel Joseph | officer | Sale | 65,892 | $329K | Aug 26, 2026 |
| Ajayi Toyin | director | Buy | 41,096 | - | Jun 4, 2026 |
| Glass Russell Monroe | director | Buy | 41,096 | - | Jun 4, 2026 |
| GRUA PETER J | director | Buy | 41,096 | - | Jun 4, 2026 |
| GUERTIN SHAWN M | director | Buy | 41,096 | - | Jun 4, 2026 |
| Jelinek Richard M | director | Buy | 41,096 | - | Jun 4, 2026 |
| KECK KIM | director | Buy | 41,096 | - | Jun 4, 2026 |
| Smith Jill D. | director | Buy | 41,096 | - | Jun 4, 2026 |
| Springstubb Brendan B | director | Buy | 41,096 | - | Jun 4, 2026 |
| Barbarosh Craig A. | director | Buy | 41,096 | - | Jun 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EVH Growth Story
Revenue YoY
-26.6%
3yr Revenue CAGR
11.5%
EPS Growth YoY
-525.93%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for EVH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EVH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 13:13:19 | $4.75 | 1,208 | $$6K | SELL |
| 22:25:52 | $4.99 | 364,100 | $$1.8M | BUY |
| 22:25:52 | $4.99 | 401,500 | $$2.0M | BUY |
| 21:00:19 | $4.99 | 1,592 | $$8K | BUY |
| 21:00:19 | $4.99 | 14,100 | $$70K | BUY |
5 dark pool trades shown · $$3.9M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Evolent Health, Inc. (EVH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EVH — frequently asked questions
What is EVH stock price today?
Evolent Health, Inc. (EVH) is at $4.75, down 4.91% (-$0.25) at the Nov 12, 2026 close.
Why is EVH stock moving today?
Latest EVH news — Nov 12, 2026: Humana, Evolent Health roll out oncology care program · Nov 6, 2026: Oppenheimer keeps Outperform rating on Evolent Health, lifts price target
Why did EVH stock move on Nov 6, 2026?
Evolent Health shares closed at $4.58, up 1.55% on the day, after two analyst firms raised their price targets. Oppenheimer maintained its Outperform rating and lifted its target to $7, while Needham reiterated its Buy rating and also raised its price target.
What is the EVH price target?
The average analyst price target for EVH is $6.00, ranging from $6 to $7, based on 8 analysts. Latest: Oppenheimer maintains on Nov 6, 2026.
What do analysts rate EVH?
Analyst ratings for EVH: 1 Buy, 10 Hold, 4 Sell — consensus Hold.
Did EVH beat earnings?
EVH last reported on Nov 5, 2026: EPS $0.06 vs $0.06 expected — a miss of 1.6%.
Does EVH pay a dividend?
Yes. EVH's dividend yield is 2.44%.
What are EVH support and resistance levels?
Support: $4.54, $4.08, $3.71. Resistance: $4.95, $5.52, $6.00.
What are insiders doing with EVH?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on EVH?
Nov 12, 2026: Humana, Evolent Health roll out oncology care program · Nov 6, 2026: Oppenheimer keeps Outperform rating on Evolent Health, lifts price target · Nov 6, 2026: Oppenheimer keeps Outperform rating on Evolent Health, lifts target to $7